The medium and long-term debt of pharmaceutical firm Unimed listed on Tunisia stock exchange grew by 448% year to year in S1, 2019 to reach TND20.8 million.
The firm explains that during the period under review, it borrowed TND4.8 million from banks for its expansion project.
According to Moroccan media citing Charfeddine Ridha (photo), UNIMED’s managing director, an TND80 million-investment plan is announced for the expansion of the firms’ laboratories.
Despite the growth of its debt, Unimed’s turnover rose by 124% year on year to reach TND31.1 million thanks to its sales on local and foreign markets that quarter.
Chamberline MOKO
(EBID) - EBID aims to allocate nearly 41% of its commitments to projects with environmental and...
Mahindra & Mahindra is considering a CKD assembly plant near Durban to strengthen its presence i...
Four major operators—Mauritel, Mattel, Rimatel, and Chinguitel—submitted a combined bid of ...
AFC disbursed €43 million for Côte d’Ivoire solar project Financing supports 66 MW pla...
Operators review 2025 investments, outline 2026 expansion plans Consumer complaints persist...
85.8% of Malawi’s 8,939 schools lack internet access despite national digital ambitions. Nearly 47% of schools have no electricity, making...
Total traffic rose to 29.66 million tonnes in 2025, up from 24.58 million tonnes in 2024. Liquid bulk volumes surged 108%, while imports and...
Caledonia Mining reported lower Q1 2026 output at Blanket mine but maintained full-year guidance. The company targets 72,000–76,500 ounces...
Cap Holding secured approval to acquire 68% of Forafric Maroc, a major wheat processor. The deal strengthens Cap Holding’s position across...
The Virunga Gorilla Marathon is a relatively recent initiative held in the Virunga region, a volcanic mountain range straddling the borders of the...
Lomé is hosting the 9th edition of the International Film Festival of Togo (FIFTO) featuring 33 films. The event promotes African storytelling in...